Network analysis predicts that the results exhibit targets related to both NAFLD and active compounds in FFDZ, which mainly enrich the insulin resistance, AMPK signaling pathway, and PPAR signaling pathway (Supplementary Figure S1). This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.